Gannett to Participate at the UBS Global Media and Communications Conference

NEW YORK, NY--(BUSINESS WIRE)-- Gannett Co., Inc. (“Gannett”, “we”, “our”, or the “Company”) (NYSE: GCI) today announced that its Chairman and Chief Executive Officer, Michael Reed, and its Chief Financial Officer, Doug Horne, will participate at the following conference:

UBS Global Media and Communications Conference
Monday, December 9, 2024
One-on-one investor meetings throughout the day
New York, New York

About Gannett

Gannett Co., Inc. (NYSE: GCI) is a diversified media company with expansive reach at the national and local level dedicated to empowering and enriching communities. We seek to inspire, inform, and connect audiences as a sustainable, growth focused media and digital marketing solutions company. We endeavor to deliver essential content, marketing solutions, and experiences for curated audiences, advertisers, consumers, and stakeholders by leveraging our diverse teams and suite of products to enrich the local communities and businesses we serve. Our current portfolio of trusted media brands includes the USA TODAY NETWORK, comprised of the national publication, USA TODAY, and local media organizations in the United States, and Newsquest, a wholly-owned subsidiary operating in the United Kingdom. Our digital marketing solutions brand, LocaliQ, uses innovation and software to enable small and medium-sized businesses to grow, and USA TODAY NETWORK Ventures, our events division, creates impactful consumer engagements, promotions, and races.

Our website address is www.gannett.com. We use our website as a channel of distribution for important company information, including press releases and other news and presentations, which is accessible on the Investor Relations and News and Events subpages of our website.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241202963838/en/

For investor inquiries, contact:
Matt Esposito
Investor Relations
703-854-3000
[email protected]

For media inquiries, contact:
Lark-Marie Anton
Corporate Communications
646-906-4087
[email protected]

Source: Gannett Co., Inc.

You May Also Be Interested In

• Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European
• Meme Coin Market Heats Up: SHIB and PENGU Rally While the Next Best Meme Coin Presale Launch Countdown Reaches 10 Days 
• Is AI Car Diagnostics Worth It for DIY Owners? Tyler-powered THINKCAR Scanners Give DIYers a Diagnostic Solution